Dr. Shai N. Gozani, CEO of pain-treating TENS device company NeuroMetrix (NSDQ:NURO), is cutting his annual salary to $1 from a previous $422,200 — accepting a stock option to purchase 100,000 shares instead. The 2020 executive compensation package, approved Dec. 29 by the company board’s compensation committee, also cuts salaries in return for stock options for […]
Medtronic pain pump recall deemed Class I
The FDA has classified the recall of Medtronic’s (NYSE:MDT) SynchroMed II implantable drug pumps as Class I, the most serious type of recall. The company announced the voluntary recall in October, saying that it had received complaints about the pumps’ motors stalling permanently. Permanent motor stall could prevent the infusion of drugs to the patient, […]
SPR Therapeutics announces 1000th placement of nerve stimulation device
SPR Therapeutics announced the 1000th commercial placement of its Sprint peripheral nerve stimulation (PNS) system for treating pain. Dr. Henry Vucetic of University Hospitals Case Medical Center (Cleveland) performed the 1000th procedure, treating a patient with shoulder pain due to osteoarthritis. The Sprint PNS system is the only percutaneous PNS device cleared by the FDA […]
Micro-Leads collects $10m for neuromod therapy
Clinical neurostimulation startup Micro-Leads announced that it was awarded $10 million by a National Institutes of Health initiative for funding therapy development. Somerville, Mass.-based Micro-Leads develops the HD64 implantable therapy system for spinal cord stimulation. The device is designed to treat lower back pain and focal pains of the trunk and extremities by delivering electrical […]
Stimwave Technologies stops commercialization of products in Australia
Stimwave Technologies announced today that it is stopping the commercialization of its product lines in Australia until its entire product family can be legally marketed in the country. The neuromodulation therapy alternative developer’s products include the Freedom SCS system and the StimQ PNS system, which are designed to reduce the risks associated with implantable pulse […]
This injectable electrode could lower the cost of neuromodulation therapy
Researchers at the University of Wisconsin-Madison have developed an injectable, flexible electrode that could replace rigid nerve-stimulating implants and reduce the cost of neuromodulation therapy. The researchers’s new type of electrode can be injected as a liquid and cure within the body. Traditional neuromodulation treatments require surgically implanted devices that can cost up to six […]
The top 10 medical disruptors of 2020
For the past 17 years, the Cleveland Clinic has predicted what the top 10 medical disruptors will be for the following year. The list of technologies, cultivated by a panel of physicians and scientists at the clinic, was led by Dr. Michael Roizen, emeritus chief wellness officer. “Healthcare is ever-changing and we anticipate that these […]
DeviceTalks Q&A: Talking targeted pain management with CEO Maria Bennett
At DeviceTalks Minnesota 2019, SPR Therapeutics founder, president & CEO Maria Bennett spoke with DeviceTalks program manager Sarah Faulkner about the company’s FDA-cleared peripheral nerve stimulation system for pain management. Want to see these interviews live? Join us at DeviceTalks West – Dec. 9-10 in Santa Clara, Calif. Sarah: Could you tell us a little […]
Report: Medtronic establishes $35m settlement fund for Synchromed pumps
Medtronic (NYSE:MDT) last week reportedly agreed to create a settlement fund worth some $35 million to compensate those who say they were harmed by the SynchroMed II intrathecal drug pump. The settlement involves about 500 people who claimed harm came from use of the pain-fighting pump, represented by three law firms that are negotiating individual […]
FDA approves Abbott’s recharge-free spinal cord stimulator
Abbott (NYSE:ABT) announced today that the FDA has approved its low-dose, recharge-free spinal cord stimulation system with up to 10-year battery life for people in chronic pain. The Proclaim XR neurostimulation system couples low-energy therapy with a low-dosing protocol to provide pain relief and preserve its battery. Abbott said its BurstDR stimulation waveform was designed to […]
ElectroCore plunges after FDA asks for more GammaCore data
ElectroCore (NSDQ:ECOR) shares plunged today after the company said the FDA asked for more data on a bid for an expanded indication for its GammaCore device. Basking Ridge, N.J.-based ElectroCore asked for an expanded 510(k) indication covering prevention of migraine with ElectroCore, a non-invasive vagus nerve stimulator. Today the company said the federal safety watchdog asked […]
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 35
- Next Page »
